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Abstract
Background: Surgical sterilization is a common method of contraception. There have been few studies evaluating
the effect of obesity on procedural complications with either laparoscopic or hysteroscopic methods of sterilization.
The purpose of this study was to compare the incidence of intraoperative complications of hysteroscopic tubal
occlusion with laparoscopic tubal ligation among obese and nonobese women.
Methods: This retrospective cohort study compared women undergoing interval laparoscopic or hysteroscopic
sterilization in the operating room between September 2009 and December 2011 at a single hospital. Serious
complications included: unintended surgery, uterine perforation, anaphylaxis, blood transfusion, infection requiring
antibiotics, hospital admission, fluid overload, myocardial infarction, and venous thromboembolism. Post-operative events
included: nausea/vomiting, doctor evaluation or additional pain medication required in the recovery room, and
emergency department visit within 2 weeks of surgery. The association between sterilization type and incidence of
complications was examined overall, separately by BMI group, and also among patients who received general anesthesia.
Results: A total of 433 laparoscopic and 277 hysteroscopic procedures were reviewed. The BMI distribution of the sample
was 35 % normal weight, 31 % overweight, and 34 % obese which is comparable to the general US female population.
No life-threatening events were identified. Serious complications were similar with 20 (4.6 %) in the laparoscopic group
and 11 (4.0 %) in the hysteroscopic group (p = 0.9). The most common serious complications were bleeding from the
tube, cervical laceration, and uterine perforation. Although not statistically significant, women with a BMI of 30 or greater
had only 1 (1 %) serious complication in the hysteroscopic group compared to 7 (5.2 %) in the laparoscopic group.
Postoperative events were increased in the laparoscopic group (16.2 %) compared to the hysteroscopic group (6.9 %),
especially among overweight and obese women (p <0.01). Failure to complete the intended bilateral occlusion occurred
for 14 women in the hysteroscopic group compared to just one woman in the laparoscopic group (p <0.001).
(Continued on next page)
* Correspondence: rhallen@wihri.org
This study was accepted and presented as a poster presentation at the 62nd
Annual Clinical Meeting of the American College of Obstetricians and
Gynecologists on April 26 – 30, 2014 in Chicago, IL.
Department of Obstetrics & Gynecology, Warren Alpert Medical School of
Brown University, Women & Infants Hospital, 101 Dudley St, Providence, RI
02905, USA
© 2016 Shepherd et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Shepherd et al. Contraception and Reproductive Medicine  (2016) 1:1 
DOI 10.1186/s40834-016-0008-3
(Continued from previous page)
Conclusion: Both laparoscopic and hysteroscopic tubal sterilization are safe with few serious complications based on
these data. No cases of laparotomy, blood transfusion, or life-threatening events were identified. There was no difference
in serious complication rate by sterilization method. Overweight and obese women were no more likely to experience a
serious complication with either method than women with a BMI <25. There were fewer postoperative events (p <0.01)
with hysteroscopic sterilization, but far fewer failed laparoscopic procedures (p <0.001). These study findings can be used
to enhance sterilization counseling.
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Background
Surgical sterilization is one of the most commonly used
methods of contraception for women in the United
States with over 600,000 procedures performed each year
[1]. The landmark United States Collaborative Review of
Sterilization (CREST) study analyzed complication rates
among 9,475 women undergoing interval laparoscopic
tubal ligation (LTL) from 1978 to 1987. Complications,
defined as performance of an unintended major surgery at
the time of sterilization, occurred in 0.9 per 100 women
[2]. This strict definition of complications did not include
post-operative events that a patient might factor into her
decision to proceed with an elective sterilization. Unlike
LTL, hysteroscopic sterilization (HS) does not require an
abdominal incision or peritoneal cavity distention. A
British study which defined complications broadly includ-
ing vasovagal reactions, cervical tear and bleeding, tubal
perforation, uterine perforation, postoperative pain, and
nausea/vomiting found that outpatient HS was associated
with fewer complications than operating room LTL (11 %
vs. 27 %) [3].
The relationship between obesity and complication
rates with different types of surgical sterilization has not
been completely elucidated. With the high prevalence of
obesity in the US, health care providers need data to
assess the risks associated with surgical contraception in
obese women [4]. Overweight and obese women are
more likely to opt for tubal sterilization compared to
normal weight women [5, 6]. Providers often counsel
obese women that laparoscopic sterilization may be as-
sociated with a higher risk of complications compared to
hysteroscopic sterilization. Indeed, the CREST study
concluded that obese women have a slightly higher risk
of complications with laparoscopic tubal ligation com-
pared to nonobese women (OR 1.7; 95 % CI 1.2, 2.6) [2].
However, there is a paucity of objective data to verify
that that HS is a safer option for obese women. The
goals of this study were to compare the risk of complica-
tions between HS and LTL and to stratify complication
rates by BMI. We hypothesized that complication rates
would be higher with laparoscopic tubal sterilization
compared to hysteroscopic, and that obese women
undergoing surgical sterilization would have a higher
risk of complications compared to non-obese women.
Methods
This retrospective cohort study compared all women
who underwent interval LTL and HS at a large academic
women’s hospital between September 2009 and December
2011. Cases were identified by a search of the hospital’s
electronic medical record by surgical procedure. At the
time of the study, all laparoscopic procedures and the
majority of hysteroscopic sterilization procedures in the
community were performed in the hospital’s operating
room. The choice of sterilization procedure was at the dis-
cretion of the surgeon. The type of laparoscopic occlusion
was identified from the operative report. Data were
collected from medical records and included information
on demographics, medical and surgical history from the
admission note, surgical procedure, and any intraoperative
or postoperative complications. Overall surgical and re-
covery room times were collected from the medical record
as documented by nursing staff. Any emergency depart-
ment visit within 2 weeks of surgery was recorded and the
physician notes were reviewed to determine if the visit
was related to the surgery. This study was approved by the
Women & Infants Hospital Institutional Review Board.
The main independent variables were body mass index
(BMI) and type of sterilization (LTL vs. HS). BMI was
categorized according to standard criteria: less than
25 kg/mg2, normal weight; 25 to 29.9 kg/m2, overweight;
and 30 or more kg/m2, obese [7]. Height and weight
were routinely measured on the day of surgery by the
preoperative staff. The dependent variables were serious
complications and post-operative events. Serious compli-
cations included: unintended surgery (laparotomy, major
blood vessel repair, resection of tube, bleeding from tube,
oophorectomy, or repair of the bowel, bladder, cervix, or
uterus), life-threatening event (anaphylaxis, myocardial
infarction, and venous thromboembolism), uterine perfor-
ation, blood transfusion, infection requiring antibiotics,
hospital admission, and fluid overload leading to pulmonary
edema. Post-operative events included: nausea/vomiting,
doctor evaluation in the post-anesthesia care unit (PACU),
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pain requiring additional medication in the PACU (defined
as more than the standard single dose of postoperative pain
medication), and an emergency department visit within
2 weeks of surgery. Patients with multiple serious complica-
tions or post-operative events were counted only once in
each applicable category of complications for data analysis.
We also collected information on whether the procedure
was able to be performed as intended or whether conver-
sion to laparoscopy or laparotomy was required.
The sample size calculation focused on detecting a higher
incidence of complications (serious and/or postoperative)
among laparoscopic sterilization patients, compared to
hysteroscopic sterilization patients. The null hypothesis was
no difference in the incidence of complications between the
two procedures. Based on a literature review and
institution-specific data, we assumed that the incidence of
having any complication was 7 and 2 % for the laparoscopic
and hysteroscopic groups, respectively. After an initial
review of medical records, we estimated that there were
approximately twice as many laparoscopic sterilizations as
hysteroscopic sterilizations. Therefore, we used a ratio of
2:1 for the comparison groups in our calculation, as
opposed to assuming equally-sized groups. We estimated
that 474 laparoscopic and 237 hysteroscopic patients were
required to detect a 5 % absolute difference (7 % vs. 2 %) in
the incidence of any complication with a two-sided alpha of
0.05 and 80 % power.
Statistical analyses were performed using STATA 10
software (StataCorp, College Station, TX). Categorical
variables were analyzed by chi-square and Fisher’s exact
tests and continuous variables were analyzed by T test
and Wilcoxon rank-sum test. The association between
sterilization type and incidence of complications was
examined overall, separately by BMI group, and also
among patients who received general anesthesia. All
p-values are two-tailed with p <0.05 considered statis-
tically significant.
Results
During the study period, 710 women underwent interval
surgical sterilization, 433 via the laparoscopic approach
and 277 via the hysteroscopic approach. Of the laparo-
scopic procedures, 407 (94 %) were performed with
Falope rings, the remainder with bipolar tubal coagula-
tion. The hysteroscopic sterilization method utilized in
all cases was Essure (Bayer Healthcare Pharmaceuticals,
Whippany, NJ). The mean age was 33.7 years (±6.3) and
there was no significant difference in gravidity, parity,
history of abdominal surgery or medical comorbidities
between the two groups (Table 1). More women in the
hysteroscopic sterilization group had Medicaid insurance
(55.1 %) compared to the laparoscopic group (46.3 %). A
total of 234 (33.6 %) women were obese. The hystero-
scopic sterilization group had a slightly higher mean
Table 1 Clinical characteristics of study sample by method of









Mean (SD) 33.7 (6.3) 33.6 (6.2) 33.9 (6.5) 0.6
Race/ethnicity
Hispanic/Latina 201 (30.0) 121 (29.7) 80 (30.4) 0.5
White 362 (54.0) 224 (54.9) 138 (52.5)
Black 47 (7.0) 23 (5.6) 24 (9.1)
Asian 13 (1.9) 9 (2.2) 4 (1.5)
Other 48 (7.2) 31 (7.6) 17 (6.5)
Gravidity
Median (Range) 3 (0–11) 3 (0–11) 3 (0–11) 0.7
Parity
Median (Range) 2 (0–8) 2 (0–8) 2 (0–6) 0.2
Insurance
Medicaid 315 (49.7) 179 (46.3) 136 (55.1) 0.09
Private 298 (47.0) 195 (50.4) 103 (41.7)
Self-pay 21 (3.3) 13 (3.4) 8 (3.2)
BMI
Mean (SD) 28.5 (6.8) 27.9 (6.1) 29.6 (7.6) 0.002
BMI class
<25 247 (35.5) 160 (37.5) 87 (32.3) 0.04
25–29.9 215 (30.9) 133 (31.2) 82 (30.5)
30–34.9 124 (17.8) 79 (18.5) 45 (16.7)
35–39.9 68 (9.8) 38 (8.9) 30 (11.2)
≥40 42 (6.0) 17 (4.0) 25 (9.3)
Any comorbidities
Yes 326 (45.9) 193 (44.6) 133 (48.0) 0.4
No 384 (54.1) 240 (55.4) 144 (52.0)
Any abdominal surgery
Yes 288 (40.6) 179 (41.3) 109 (39.4) 0.6
No 422 (59.4) 254 (58.7) 168 (60.7)
Abdominal surgeries
Cesarean section 206 (29.0) 127 (29.3) 79 (28.5) 0.9
Appendectomy 43 (6.1) 24 (5.5) 19 (6.9) 0.5
Cholecystectomy 66 (9.3) 40 (9.2) 26 (9.4) 1.0
Umbilical hernia
repair
12 (1.7) 4 (0.9) 8 (2.9) 0.07
Gastric bypass 13 (1.8) 6 (1.4) 7 (2.5) 0.4
Other laparoscopy/
laparotomy
59 (8.3) 39 (9.0) 20 (7.2) 0.5
Mean (SD) or number (%). Numbers may not sum to total due to missing data:
race/ethnicity (n = 39, 5.5 %), number of cesarean sections (n = 39, 5.5 %),
gravidity (n = 18, 2.5 %), parity (n = 10, 1.4 %), insurance (n = 76, 10.7 %), and
body mass index -BMI (n = 14, 2.0 %)
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BMI of 29.6 kg/m2 compared to 27.9 kg/m2 for the
laparoscopic group (p = 0.002) (Table 1). All of the
laparoscopic tubal ligations and the majority of the
hysteroscopic sterilizations (72 %) were performed under
general anesthesia. Both surgical time and recovery time
were greater for the LTL group than the hysteroscopic
group (Table 2). Estimated blood loss was low for both
procedures (<25 mL).
The overall incidence of serious complications was
4.4 % for both laparoscopic and hysteroscopic sterilization.
Overall, the most common serious complication in the
LTL group was bleeding from the tube with a total of ten
cases (Table 3). In contrast, the most common serious
complication in the hysteroscopic group was uterine
perforation with four cases. No cases of laparotomy,
blood transfusion, infection requiring antibiotics, or
life-threatening events were identified with either
sterilization approach. No statistically significant differences
were noted in serious complication rates by weight category
between sterilization methods (Table 4). The one group
that had a lower risk was obese women receiving HS. No
clear trends emerged to suggest an underpowered negative
result. This did not change when the data were controlled
for prior abdominal surgery (data not shown). The seven
serious complications among the obese women in the LTL
group included two cervical repairs, two episodes of bleed-
ing from the tube, one bleeding from tube and resection of
tube, one uterine perforation, and one hospital admission.
The one serious complication among obese women in the
hysteroscopic group was fluid overload.
Failure to perform the intended procedure occurred
for 14 women (5 %) in the hysteroscopic group com-
pared to just one woman (0.2 %) in the laparoscopic
group (p <0.001). Of these 14 cases, there were seven
among normal weight women, six among overweight
women, and 1 in an obese woman. Eight were caused by
an inability to pass the microinsert catheter into the
tubal ostia or failure to deploy the microinsert, three
were due to inadequate visualization of the tubal ostia,
and three were attributable to suspected uterine
perforations. Nine of these cases were converted to
laparoscopic tubal ligations and one woman had a
copper intrauterine device (IUD) placed. For the hys-
teroscopic sterilization group, follow-up hysterosalpin-
gogram (HSG) data were available for 178 women
(64 %). Among these women, 167 (94 %) HSGs dem-
onstrated bilateral tubal occlusion on the three-month
HSG. The remainder of the women are either pre-
sumed to not have followed-up for the HSG or ob-
tained the test at an outside institution. The outcome
of repeat 6-month HSGs is not known. In the lapar-
oscopy group, one woman was not sterilized because
dense pelvic adhesions obscured the tubes. A laparotomy
was not performed.
The overall incidence of postoperative events was
16.2 % for laparoscopic and 6.9 % for hysteroscopic
sterilization. More women in the laparoscopic group
required additional medications for pain in the PACU
and more visited the emergency department visit within
2 weeks after surgery for abdominal pain (71 %) related
to the surgery, followed by wound complaints (12.5 %)
(Table 5). The other four visits were for chest pain, urinary
retention, dizziness, and constipation. There were no
hospitalizations as a result of these visits. When stratified
by BMI and receipt of general anesthesia, there was no
significant difference between the laparoscopic approach
and the hysteroscopic approach in incidence of postopera-
tive events for normal weight and overweight women
(Table 6). Among obese women, there was a statistically
significant increase in incidence of postoperative events
with the laparoscopic approach (17.2 %) when compared
to 6 % with the hysteroscopic approach (p=<0.05).
Table 2 Surgical characteristics of sample by method of sterilization
Total Laparoscopic Hysteroscopic p-value
Type of anesthesia
General 630 (89.2) 433 (100) 197 (72.2) <0.0001
Local only 8 (1.1) 0 8 (2.9)
Spinal 9 (1.3) 0 9 (3.3)
Intravenous
sedation
59 (8.4) 0 59 (21.6)
Surgical time
(minutes)
Median (IQR) 23 (15–34) 29 (21–40) 15 (11–22) <0.0001
Recovery time
(minutes)
Median (IQR) 70 (58–89) 72 (60–90) 66 (55–86) 0.005
Estimated blood
loss (cc)
Median (IQR) 10 (5–20) 10 (5–20) 5 (5–10) <0.0001
Number (%). Numbers may not sum to total due to missing data: anesthesia
type (n = 4, 0.6 %), and estimated blood loss (n = 17, 2.4 %)
IQR = interquartile range








Resection of tube 2 (0.5) 1 (0.4) 1.0
Bleeding from tube 10 (2.3) 2 (0.7) 0.1
Cervical repair 4 (0.9) 3 (1.1) 1.0
Uterine perforation 2 (0.5) 4 (1.4) 0.2
Fluid overload 0 1 (0.4) 0.4
Hospital admission 4 (0.9) 0 (0) 0.2
aThere were no cases of laparotomy, repair major blood vessel, oophorectomy,
bladder repair, uterine repair, bowel repair, anaphylaxis, infection requiring
antibiotics, transfusion, myocardial infarction, or venous thromboembolism
bFor each complication listed, the values presented are the number of patients
with the complication and the proportion out of all patients in each group
The p-values were calculated separately for each complication
Shepherd et al. Contraception and Reproductive Medicine  (2016) 1:1 Page 4 of 7
Discussion
In this retrospective cohort study, there was a greater
incidence of postoperative events among obese women
who had a laparoscopic sterilization compared to obese
women who had hysteroscopic sterilization after control-
ling for receipt of general anesthesia. No life-threatening
complications were noted. Serious complications were too
infrequent to discern a difference among BMI categories
when comparing sterilization methods. The serious com-
plication rate ranged from 3.8 to 6.1 % for all categories
except in obese women sterilized by hysteroscopy who
only had a 1 % complication rate. No statistically
significant difference was noted. More women in the
hysteroscopic group had failed procedures compared to
the laparoscopic group, unrelated to obesity. The rate of
failure of microinsert placement in this study (5 %) is no
different than that reported in the literature for these pro-
cedures [8]. Similar to another study, in this investigation
BMI did not influence success of bilateral microinsert
placement [9].
Although previous studies on female sterilization have
compared the risk of complications for LTL and HS
methods in a general population and the risk of compli-
cations for obese women undergoing laparoscopic
sterilization, this is the first research on the safety of
hysteroscopic sterilization for obese women. Hystero-
scopic sterilization was safe for obese women with the
most common serious complication being uterine perfor-
ation (1.4 %). The incidence of other serious complications
was extremely low.
While surgical sterilization overall is very safe, the avail-
ability of equally effective long-acting reversible contra-
ceptives (IUDs and implants) is important to consider.
Women desire to understand the risk of surgery and how
their BMI may alter their risk of a surgical complication or
a complicated post-operative recovery. The American Col-
lege of Obstetricians and Gynecologists recommends min-
imally invasive approaches for surgery in obese women if
possible [10]. Laparoscopy in the morbidly obese may re-
quire special surgical techniques in terms of instruments
and trocar placement [11]. In terms of approach, the
hysteroscopic method is less invasive than the laparo-
scopic method of sterilization and may be preferred in
obese women provided they are willing to comply with the
3-month hysterosalpingogram requirement and under-
stand the success rate of bilateral tubal occlusion with the
microinserts. All women, including obese women, should
be offered long-acting reversible contraceptives (LARC) as
an alternative to sterilization. In addition, vasectomy for
the male partner should be discussed as it would obviate
risks for the obese woman entirely.
The strengths of this study include a large, diverse
patient population undergoing surgery with multiple
academic faculty and community-based providers.
There is no one standard way to define serious or
major complications for elective surgery. Since tubal
sterilization is considered an elective procedure and
safer options with equal efficacy are available (LARC),
a broader definition of complications was selected
that included postoperative adverse events in addition
to the usual intraoperative events. These minor events
may be significant to a patient choosing between surgery
or less invasive contraceptive methods or in selecting the
specific type of sterilization. A weakness of the study
is that complications were not classified via a vali-
dated system.
A limitation to this study was the exclusion of
women who had outpatient procedures. At the time
the study was performed, the majority of hystero-
scopic and laparoscopic sterilizations in the commu-
nity were performed in the hospital operating room.
Nevertheless, previous research has found no signifi-
cant difference in complication rates between HS per-
formed in-office and those performed in a hospital
operating room [8, 9]. Furthermore, controlling for
the receipt of general anesthesia did not alter the
results. Data collection was confined to available






Nausea/vomiting 6 (1.4) 3 (1.1) 1.0
Doctor evaluation in PACU 20 (4.6) 10 (3.6) 0.6
Pain requiring add’l meds 37 (8.6) 9 (3.3) 0.005
Emergency department visit
within 2 weeks
21 (4.9) 3 (1.1) 0.005
Number (%). PACU post-anesthesia care unit aPatients with more than one
complication are counted in each applicable complication
Table 4 Incidence of serious complication by BMI and method of sterilizationb (N = 710)
Serious complicationa Total Laparoscopic (n = 433) Hysteroscopic (n = 277) OR (95 % CI) P value
Overall 31 (4.4) 20 (4.6) 11 (4.0) 0.9 (0.4-1.9) 0.9
BMI <25 12 (4.9) 7 (4.4) 5 (5.8) 1.3 (0.3-5.0) 0.8
BMI 25–25.9 10 (4.7) 5 (3.8) 5 (6.1) 1.7 (0.4-7.5) 0.5
BMI ≥30 8 (3.4) 7 (5.2) 1 (1.0) 0.2 (0.004-1.5) 0.1
Number (%). BMI body mass index
aPatients with more than one serious complication are counted just once
bNumbers may not sum to total due to missing BMI data (n = 14, 2.0 %)
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surgical and medical records and therefore did not
account for long-term complications like failure of
the sterilization (pregnancy) or patient-reported out-
comes such as satisfaction and quality of life. In
addition, the choice of sterilization procedure was at
the discretion of the surgeon and likely based on
multiple factors including patient BMI, history of
abdominal surgery and medical problems, and prefer-
ence of the surgeon. As a retrospective study, poten-
tial bias includes the selection of the procedure.
Women with a BMI ≥40 were over twice as likely to
receive hysteroscopic sterilization. In addition, data
on surgeon experience was not collected for this
study. How surgeon experience may have affected the
results is uncertain. Finally, given that the vast majority of
laparoscopic procedures were performed with the Falope
Ring, whether other modalities would have been associ-
ated with less postoperative pain is unknown.
Studying the experience of women with varied BMI
who select surgical sterilization is important because
studies who that obese women are more likely to
choose surgical sterilization [5, 12]. These data define
the incidence of complications and the postoperative
experience from laparoscopic compared to hystero-
scopic sterilization by BMI. While the data are from a
single institution, the demographic of the population
is similar to many populations in the US and will
improve the provider’s ability to thoughtfully tailor
counseling, based on their BMI, about risks and
adverse experiences to patients considering elective
surgical sterilization.
Conclusions
Both laparoscopic and hysteroscopic tubal sterilization
are safe with few serious complications based on these
data. No cases of laparotomy, blood transfusion, or life-
threatening events were identified. There was no
difference in serious complication rate by sterilization
method. Overweight and obese women were no more
likely to experience a serious complication with either
method than women with a BMI <25. There were fewer
postoperative events (p <0.01) with hysteroscopic
sterilization, but far fewer failed laparoscopic proce-
dures (p <0.001). These study findings can be used to
enhance sterilization counseling.
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